4 ms·
Although the linked article does not address it, the FDA is certainly working to mitigate any fallout from the plant closure. Much of the complexity is that WIC
by rilezg 4y ago
Although the linked article does not address it, the FDA is certainly working to mitigate any fallout from the plant closure. Much of the complexity is that WIC is administrated at the state level, so the FDA must work with each state individually to address the shortage.
Of particular note:
>more infant formula has been produced in the last four weeks than in the four weeks that preceded the recall, despite one of the largest infant formula production facilities in the country being offline during that time.
https://www.usda.gov/media/press-releases/2022/05/13/usda-continues-urgent-actions-address-infant-formula-shortage https://www.usda.gov/media/press-releases/2022/05/13/usda-co...
- landemva 4y ago>>> FDA is certainly working to mitigate any fallout from the plant closure. This should not be the role of the regulator. Let the FDA set standards and check for compliance.
- rilezg 4y agoMy mistake. The press release is actually from the USDA, and this is the only mention of the FDA: >USDA has been working closely with FDA to ensure program participants and stakeholders have the information they need to keep infants safe I apologize for any confusion.